Background: Coffee is one of the most widely consumed beverages in the world and it has been demonstrated that it has important therapeutic activities not only because of its caffeine content but also owing to the presence of other biologically active small molecules such as chlorogenic acid, trigonelline and cyclopentadiones. However, chlorogenic acid is degraded into catechol, pyrogallol and hydroxyhydroquinone, which are thought to induce irritation of the gastric mucosa. To reduce the content of irritant compounds processing methods have been developed prior to roasting the coffee beans.
coffee bean extract reduced the expression of proinflammatory cytokines TNF, IL-11, and IL-6 and the expression of cyclooxygenase (COX)-2 in colonic tissues.
Conclusions:
This work identified processed coffee as an anti-inflammatory beverage with the capacity to reduce substantially DSS-induced colitis as well as the colitis-associated cellular inflammatory events.
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BACKGROUND:
Diet and lifestyle are known to play a major role in the development of many diseases associated with subclinical chronic inflammation. Thus, dietary compounds are of special relevance for improving the body's defenses against such diseases. There is increasing evidence that coffee, one of the most widely consumed beverages in the world, is associated with a reduced risk to develop chronic diseases for which inflammation is a major driving force [1] . For instance, coffee consumption has been associated with a reduced risk of neuroinflammatory diseases [2] , chronic liver diseases [3.4] , cardiovascular diseases [5] , and type 2 diabetes mellitus [6] . Moreover, a meta-analysis study revealed a potential protective role of coffee in colon carcinogenesis [7] , which has been associated with inflammation [8] .
However, the precise mechanisms of action of coffee and/or coffee compounds have not been elucidated yet.
Many of the biological activities of coffee are mediated by caffeine, but the antioxidant activity of coffee is mainly ascribable to phenolic compounds such as chlorogenic acid, diterpenoid compounds such as kahweol, cafestol and reaction products known as Maillard products formed during the roasting process [9] . Some degradation products of chlorogenic acid such as pyrocatechol, hydroxy-hydroquinone and pyrogallol are potential gastric irritant substances present in coffee drinks. To reduce stomach mucosal irritation green coffee beans are treated with steam under certain conditions of temperature, pressure, vacuum and humidity over a period of 2-3 h to reduce the content of chlorogenic acid and to manufacture a "stomach-friendly" coffee [10] . Such processed coffee induced significantly less mucosal irritation in healthy volunteers [11, 12] .
In addition to anti-irritant effects in gastric mucosa, processed coffees apparently retain some of the beneficial activities attributed to non-processed coffee. For instance, coffee extracts inhibit LPS-induced nuclear factor kappa-B (NF-B) activation and induce the cellular antioxidant defense through the activation of the Nrf2 pathway. Interestingly, the degree of roasting was critical for the level of the anti-NF-B and antioxidant activities [13] . Furthermore, the activation of phase II detoxifying enzymes in the liver of mice fed with coffee has been reported [14] . Interestingly, neither chlorogenic acid nor other phenolic compounds present in the coffee were found to inhibit LPS-induced NF-B activation or induce Nrf2-dependent transcription. Moreover, filtered ground-up coffee, which lacks most of the initial diterpene content, is also a potent inhibitor of LPS-induced NF-B activation [13] .
Chronic inflammatory bowel diseases (IBD), mainly ulcerative colitis and Crohn's disease are naturally remitting and recurring conditions of the digestive tract. The pathophysiology of IBD is related to an exacerbated immune response in which macrophage hyperactivation plays a key role. Moreover, chronic inflammatory conditions such as those occurring in the gastrointestinal tract of IBD patients are known to increase the risk of colorectal cancer [14] . Indeed, inflammation is associated with 15-20% of all cancer deaths [15, 16] . The STAT3 (Signal transducer and activator of transcription 3) and NF-B signaling pathways play crucial roles in colonic inflammation and in inflammation-induced cancer [17] [18] [19] .
The aim of the present study was to test the intestinal anti-inflammatory effects of dietary administration of a commercially available processed coffee (Idee Coffee) in the DSS model of colitis, an experimental model of intestinal inflammation that has some of the histological and biochemical features of the human disease [20] . As mentioned above, in previous studies this coffee has been described as stomach friendly 11, 12] , and we therefore were interested if this processed coffee also reveals anti-inflammatory effects. Special attention was paid to the effects exerted by coffee on the production of some of the macrophage-derived mediators involved in the inflammatory response.
METHODS:
Coffee. Commercially available coffee samples (typically ground to a fine powder after roasting) were prepared from beans, which had been treated by a special roasting and processing method before grinding [10] . The coffee extracts (arabica variety) tested in this study were prepared by the following method: The extracts, i.e., their special fine coffee powder, was delivered by Darboven in vacuum containers and stored at 4 o C. Twenty grams of each dry coffee sample was dissolved in 250 ml of water and boiled for 10 min ("brewed"), and the coffee solution was allowed to stand and settle. When it had cooled to room temperature it was filtered through Whatman filter paper (GE Healthcare Europe, Barcelona, Spain). Fresh coffee was prepared every morning.
Animals. C57BL/6J wild-type mice were purchased from Charles River (Barcelona, Spain) and bred in our facilities. Before treatment 8-10 week old mice were housed under standard conditions and supplied with drinking water and food ad libitum. Water was substituted with diluted (50%/50% coffee/water vol/vol) or undiluted coffee at least 2 weeks before DSStreatment and we found that the animals did not reject the drink. During this acclimation period no changes in behavior were detected. All experiments were performed according to the Institutional Guidelines for the Care and Use of Laboratory Animals in Research and with the approval of the local ethics committee of the University of Cordoba.
Colitis induction. The animals (n=6 each group) were treated with 2.5% dextran sodium sulfate (DSS, m.w. 36-50 kDa) (MP Biomedicals, Irvine, CA, USA) either in the drinking water or in the coffee beverage over five days, followed by 4 days of regular water or coffee. A sweetener was added to the beverage consumption during the DSS treatment and the amount of liquid drunk was monitored daily. Daily clinical assessment of DSS-induced colitis was performed, including measurement of food intake and body weight, evaluation of stool consistence, and testing for the presence of blood in the stools by a guaiac paper test. Stool consistence was assessed using the following 4-point scale: 0, normal; 1, loosely shaped pellets; 2, amorphous, moist pellets; 3, diarrhea; 4, presence of blood. The rate of survival was 100%. The mice were sacrificed at day 7 by CO 2 and colon removed, measured and divided longitudinally to use half sample for protein or RNA extraction (n=3 samples per group) and the other half for inclusion in paraffin as indicated.
Histological analysis.
Intestines were removed and processed by standard procedures. In brief, colons were fixed as "Swiss rolls" overnight in 10% neutral buffered formalin. Then colons were washed with PBS and transferred into 70% ethanol, processed and embedded into paraffin. Sections of the size of 5 m were cut for hematoxylin and eosin staining.
RNA analysis and RT-PCR determination. Total RNA was extracted from frozen colons using an RNAeasy Mini Kit (Qiagen, Hilden, Germany). Disruption and homogenization of the tissue was performed using a rotor-stator homogenizer (T10 basic Ultra-Turrax, IKA, Staufen, Germany). DNase-treated RNA (1 g) was used for the synthesis of cDNA with SuperScript II Reverse Transcriptase (Invitrogen, San Diego, CA, USA) according to the manufacturer's instructions. Reverse Transcriptase-PCR (RT-PCR) amplification was performed in a 50 l PCR reaction mixture containing 1 to 5 l of the retro-transcription mixture, 1x PCR buffer, 1.5 mM MgCl 2 , 200 M dNTPs, 10 M each of 5´ and 3´ primers, and 2.5 units of recombinant TaqDNA polymerase. The mixtures were amplified in a MultiGene cycler IR system (Labnet, Labnet, Woodbridge, NJ, USA). The amplification protocol consisted of an initial denaturation for 3 min at 95 ºC and then 40 cycles of 30 s at 95 ºC, annealing for 30 s at 55 ºC (COX-2; TNF and IL-6) or 50ºC (IL-11), and elongation for 30 s at 72 ºC. A cycle of 10 s at 83 ºC and a final extension for 30 s was carried out at 72 ºC. The primers used to detect inducible proinflammatory genes were: COX-2: Forward: 5´ TGAGCAACTATTCCAAACCAGC 3´; Reverse: 5´ GCACGTAGTCTTC GATCACTATC 3´ TNF: Forward: 5´-ACGGCATGGATCTCAAAGAC-3´; Reverse: 5´ GTGGGTGAGGAGCAC GTAGT 3 ´ IL-6: Forward: 5´ GTATGAACAACGATGATGCACTTG 3´; Reverse: 5´ATGGTACTCCAGA AGACCAGAGGA 3 IL-11: Forward: 5´ CTGCACAGATGAGAGACAAATTCC 3´; Reverse: 5´ GAAGCTGCAAA GATCCCAATG 3´ GAPDH: Forward: 5´ TGGCAAAGTGGAGATTGTTGCC 3´; Reverse: 5´ AAGATGGTGAT GGGCTTCCCG 3´ Western blot analysis. The intestines were opened up and snap-frozen at -80ºC and were kept there until processed for protein extraction. Comparable amounts of tissue from distal or medial colon were homogenized with Ultra-Turrax in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 10% NP40) and supplemented with phosphatase inhibitors (500 mM NaF, 200 mM Na 3 VO 4 ) and protease inhibitors (Leupeptin, Aprotinin, Pepstatin, saturated PMSF). Western blotting was performed and immunodetection of specific proteins was carried out with primary antibodies: p-IB (Ser 32/36), p-STAT3 (Tyr705) (Cell Signaling, Danvers, MA, USA), and -Tubulin (Sigma-Aldrich, ST Louis, MO, USA), using an ECL system (GE Healthcare Europe, Barcelona, Spain).
Isolation of human peripheral monocytes.
Monocytes from healthy human donors were prepared following a standardized protocol (Ficoll gradient preparation, GE Healthcare Europe GmbH, Freiburg, Germany) using a completely endotoxin-free cultivation). Using 50 ml tubes, 25 ml Ficoll was loaded with 25 ml blood of buffy coats from healthy blood donors. The gradient was established by centrifugation at 1800 rpm, at 20 o C for 40 min using slow acceleration and braking. Peripheral blood mononuclear cells in the interphase were carefully removed and re-suspended in 50 ml pre-warmed phosphate buffered saline followed by centrifugation for 10 min at 1600 rpm and 20 °C. The supernatant was discarded and the pellet washed in 50 ml PBS and centrifuged as described above. The pellet was then resuspended in 50 ml RPMI-1640 low endotoxin-medium (from Invitrogen) supplemented with 10% human serum (PAA). After counting the number of cells in a particle counter (Euro Diagnostics, Krefeld), cells (10 6 /ml) were seeded in 24-well plates (2 ml) and incubated at 37°C/5% CO 2 . The medium and the non-adherent cells (lymphocytes) were removed and fresh RPMI-1640 medium containing 1% human serum was added. Monocytes were then ready to be used for the experiments.
Determination of inflammatory parameters. Measurements of the cytokines IL-6, TNF, IL-8 and IL-1, PGE 2 and 8-isoprostane were performed using commercially available EIAs (PGE 2 : Biotrend, Köln, Germany, 8-isoprostane: Cayman, distributed by Alexxa, Lörrach, Germany) and ELISA (IL-6, TNF; IL-8 and IL-1: HISS, Freiburg, Germany) kits. Cells were seeded in 24-well plates (Falcon) for EIA-/ELISA measurements. Then, 30 min prior to stimulation with LPS (10 ng/ml) cells were incubated with the coffee solutions at the indicated concentrations. After incubation at 37°C and 5% CO 2 for 24 hours, supernatants were removed, centrifuged and investigated for IL-1, IL-6, IL-8, TNF, 8-isoprostane and PGE 2 concentrations. The concentrations for IL-1 were; basal: 0 pg/ml, LPS: 1670 ± 570 pg/ml, for TNF; basal 24 ± 42 pg/ml, LPS: 7869 ± 2087 pg/ml, for IL-6 ; basal: 0 pg/ml, LPS: 20558 ± 10815 pg/ml, for IL-8; basal: 0 pg/ml, LPS: 185 ± 35 ng/ml, for PGE2 basal: 287 ± 27 pg/ml, LPS: 19767 ± 4455 pg/ml, and for 8-isoprostane; basal 9 ± 1 pg/ml; LPS: 67 ± 1 pg/ml. Original data was converted into %-values of LPS-control and the means ± SE were calculated.
Statistical Analysis.
In every assay performed, the mean and the standard deviation were calculated and plotted to visualize differences between the average values of the experimental populations. Sample population means were compared against control population means in an unpaired two-tailed Student's t test. The p value obtained from the Student's t test analysis marks the probability of rejecting the null hypothesis, that is, the events are independent, and they may be: p ≤0.05, significant (*), p ≤0.01, very significant (**) and p ≤0.005, highly significant (***).
RESULTS AND DISCUSSION:
Processed coffee inhibits the release of proinflammatory mediators in human primary monocytes. It has been previously shown that coffee inhibits LPS-induced NF-B activation in the monocyte cell line U937 [13] . Since the NF-B pathway is a master regulator of different proinflammatory mediators including cytokines [21] , we evaluated the effect of processed coffee on LPS-stimulated human primary monocytes. The cells were incubated with increasing concentrations of the coffee for 30 min and then stimulated with LPS for 24
hours. In figure 1A we show that the coffee very effectively inhibited the release of all the cytokines tested. The IC50 for TNF, IL-6 and IL-8 was calculated to be between 1 and 1.3 l/ml (vol/vol), and the IC50 for IL-1 was significantly lower (0.63 l/ml). At the concentration used we found that coffee was not cytotoxic for the cells (data not shown). The production of IL-1 in macrophages is regulated at the transcriptional and posttranscriptional levels, and therefore our results suggest that processed coffee may interfere with different targets involved in IL-1 release. We also found that coffee inhibited PGE 2 release in LPS-stimulated monocytes (Fig. 1B) . It has been shown that kahweol and cafestol inhibit COX-2 expression and PGE 2 release in a murine macrophage cell line [22] . However, most of the phenolic compounds are retained in the filter during coffee preparation and it is possible that the effects of coffee on PGE 2 release are mediated by compounds such as caffeine or by cyclopentanoids such as 3-methyl-1,2,-cyclopentadione (3-MCP). We have previously found that caffeine inhibits both COX-2 expression and enzymatic activity in primary microglia cells. Interestingly, caffeine synergizes with acetylsalicylic acid to inhibit PGE 2 release [23] . Thus, it is possible that caffeine present in the processed coffee may synergize with compounds other than polyphenols to inhibit LPS-induced proinflammatory mediators and cytokines. In this sense it has been demonstrated that 3-MCP inhibits NF-B signaling, COX-2 and IL-6 expression in an in vivo model of inflammation [24] . It should be interesting to analyze the content of 3-MCP in the processed coffee and its potential synergistic activities with caffeine. Using the measurement of 8-isoprostane as a marker of free radical generation we show here that LPS induces a prooxidative state in primary monocytes leading to accumulation of 8-isoprostane. As depicted in Fig. 1B , processed coffee also inhibited the release of 8-isoprostane in a concentration-dependent manner. The most important mechanisms associated with the toxic effects of enhanced COX activity during inflammation include production of PGE 2 and formation of free radicals leading to oxidative stress [25, 6] . Since the LPS-induced NF-B pathway is also mediated by an imbalance of the cellular redox status toward a prooxidative environment and NF-B is involved in the regulation of IL-1, TNF, IL-6, IL-8 and COX-2, it is possible that anti-oxidant compounds present in roasted coffee may account for the anti-inflammatory activities found in our experiments [13] .
Drinking processed coffee prevents DSS-induced inflammation. One of the most used experimental models of colon inflammation is the dextran sulfate sodium (DSS) model of murine colitis. This is a well-established model of intestinal inflammation, which has some histological, and biochemical features of the human disease, especially with regard to the involvement of different inflammatory mediators, including eicosanoids and cytokines. As a result of the in vitro experiments, we were interested in testing the effects of processed coffee on murine IBD. Water was substituted by diluted (50%/50% coffee/water vol/vol) or undiluted coffee at least 2 weeks before DSS-treatment (Figure 2A ). Both untreated (DSS group) and treated (Coffee groups) mice exhibited body weight loss beginning on day 4 of the DSS administration. By day 7, untreated mice exhibited a weight loss of nearly 20 % of their initial body weights, whereas in animals drinking coffee the weight loss was less evident (<10% of initial body weight) (Fig. 2B) . The score for stool consistence in untreated animals was 3.5, and this score was significantly reduced in animals that drank undiluted or diluted coffee (being 0.75 and 1.25 respectively). Macroscopically, the colon length and total intestine length were markedly shorter in the untreated mice than in those drinking coffee (Fig. 3A, 3B) . Histopathologically, untreated mice showed marked infiltration of inflammatory cells, loss of crypts, focal ulcerations and/or extensive destruction of the mucosal layer, accompanied by transmural infiltration of inflammatory cells, whereas coffee-treated mice showed mild infiltration of inflammatory cells in the mucosa and minimal loss of crypts in the group of animals that drank undiluted coffee (Fig. 4) . Next, we explored the mRNA expression of proinflammatory markers in the colon of untreated (DSS group) and treated (Coffee groups) mice. We found that drinking coffee clearly prevented the expression of the proinflammatory genes COX-2, TNF, IL-6 and IL-11, which were up regulated in the DSS group (Fig. 5A) . Furthermore, we analyzed the NF-B and STAT3 activation pathways by measuring the phosphorylation status of IB and STAT3 proteins respectively. In figure 5B it is shown that treatment with DSS induced the phosphorylation of IB and STAT3 in the colon, which was clearly inhibited in animals that drank coffee. Altogether, the results suggest that processed coffee significantly alleviates the inflammatory process in murine IBD. The protective effects of coffee in the acute model of IBD may have also significance in the prevention of inflammation-associated diseases such as cancer and degenerative diseases. Proliferation and survival of tumor cells can be deeply affected by interactions with the surrounding microenvironment provided by chronic inflammation, which promotes different stages of carcinogenesis (tumor initiation, progression, angiogenesis and metastasis). During the initial stages, immune and stromal cells provide inflammatory signals that favor malignant-cell growth [27] .
Many epidemiological and experimental studies have highlighted the relevance of inflammation as a predisposing cause of cancer [16, 17] , and coffee consumption may protect from colon carcinogenesis [7] . We have found that coffee prevents NF-B and STAT3 activation, and these transcription factors are known to regulate in a cooperative manner several proinflammatory genes, such as IL-6, IL-11, chemokines, growth factors and COX-2, which are crucial for maintaining a pro-carcinogenic inflammatory environment [19] [28] . Therefore, STAT3 and NF-B establish a feed-forward loop between cancer cells and the tumor microenvironment, thus creating a crosstalk between tumor cells and the surrounding inflammatory environment. This complex interplay between NF-B and STAT3 signaling cascades in different cell types (epithelial and inflammatory myeloid cells) has recently been deciphered in different studies using murine models of colitis-associated cancer [29] . Therefore, it was proposed that IL-6 released by myeloid cells would activate STAT3 in adjacent premalignant endothelial cells, thereby stimulating proliferation and tumor growth [30] .
CONCLUSIONS:
Our results demonstrate that processed coffee dampens a crucial mechanism in colon inflammation. Coffee contains a vast number of bioactive compounds that are retained after bean processing and roasting. Therefore, a "stomach friendly coffee" may not only prevent gastric irritation but its consumption may be also of nutritional importance for the management of chronic inflammatory diseases.
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